Both in Biotechnology
aTyr Pharma vs TScan Therapeutics
Over the past year ATYR returned −81.3% and TCRX returned −81.3%; their daily moves had a correlation of 0.07.
ATYR −81.3% TCRX −81.3%Growth of $1, one year, split-adjusted
| Metric | ATYR | TCRX |
|---|---|---|
| Price | $6.18 | $0.2100 |
| Market cap | $15.4M | $14.2M |
| Today | −6.79% | +11.11% |
| 1 month | −45.5% | −23.7% |
| 6 months | −85.1% | −83.2% |
| Year to date | −80.3% | −79.0% |
| 1 year | −82.5% | −83.1% |
| Revenue growth (YoY) | — | −65.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −2888.6% |
| P/E (TTM) | — | — |
| Price / sales | 81.3× | 2.0× |
| Net cash | $56.9M | $67.4M |
| Dividend yield | — | — |
| Volatility (60d) | 1,072.3% | 143.0% |
| Short % of float | 10.5% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).